Identifying good responders to glucose lowering therapy in type 2 diabetes: implications for stratified medicine.

No Thumbnail Available
Authors
Jones, Angus G.
Shields, Beverley
Hyde, C. J.
Henley, W. E.
Hattersley, Andrew T.
Journal
PloS One
Type
Journal Article
Observational Study
Research Support, Non-U.S. Gov't
Publisher
PLoS
Rights
Archived with thanks to PloS one
Defining responders to glucose lowering therapy can be important for both clinical care and for the development of a stratified approach to diabetes management. Response is commonly defined by either HbA1c change after treatment or whether a target HbA1c is achieved. We aimed to determine the extent to which the individuals identified as responders and non-responders to glucose lowering therapy, and their characteristics, depend on the response definition chosen.
Citation
Identifying good responders to glucose lowering therapy in type 2 diabetes: implications for stratified medicine. 2014, 9 (10):e111235 PLoS ONE
Note
This article is freely available online via Open Access. Click on the 'Additional Link' above to access the full text.